In brain, palmitate-induced CHOP activation decreases insulin-like growth factor 1 (IGF1) and leptin expression in vitro and in vivo; these two peptide hormones have essential implications in a variety of metabolic diseases [78]. The gene discussed is IGF1; the disease is metabolic disease.